Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 11.069% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CCOC(=O)c1c(C)[nH]c(N=Nc2ccc(C)cc2)c1C
b.) CCC(=O)Nc1ccc(NC(=S)NC(=O)/C=C/c2ccccc2)cc1
Answer: b. CCC(=O)Nc1ccc(NC(=S)NC(=O)/C=C/c2ccccc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1ccc(NC(=S)NC(=O)/C=C/c2ccccc2)cc1
CCC(=O)Nc1ccc(NC(=S)NC(=O)/C=C/c2ccccc2)cc1
(E)-3-phenyl-N-[[4-(propanoylamino)phenyl]carbamothioyl]prop-2-enamide